NCT04908800View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KRP-A218 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

May 27, 2021

Primary Completion Date

April 21, 2022

Study Completion Date

April 21, 2022

Conditions
Healthy
Interventions
DRUG

KRP-A218

KRP-A218 tablet

DRUG

Placebo

Placebo tablet

DRUG

itraconazole

10 mg/mL oral solution

Trial Locations (1)

LS2 9LH

Labcorp Clinical Research, Leeds

Sponsors
All Listed Sponsors
lead

Kyorin Pharmaceutical Co.,Ltd

INDUSTRY

NCT04908800 - A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KRP-A218 in Healthy Subjects | Biotech Hunter | Biotech Hunter